TME-SW
01698
JD HEALTH
06618
BOSS ZHIPIN-W
02076
BEKE-W
02423
TRIP.COM-S
09961
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | -128.14%-40.03M | -13.73%121.45M | -1.74%142.25M | -56.54%140.78M | 23.54%144.77M | 13.22%323.92M | -0.22%117.19M | 746.86%286.09M | 1,241.56%117.44M | -73.73%33.78M |
Profit adjustment | ||||||||||
Interest (income) - adjustment | ---- | -765.43%-21.51M | ---- | -185.63%-2.49M | ---- | 41.57%-870K | ---- | 40.68%-1.49M | ---- | -150.00%-2.51M |
Investment loss (gain) | ---- | ---- | ---- | ---- | ---- | --7.69M | ---- | ---- | ---- | ---- |
Attributable subsidiary (profit) loss | ---- | -138.47%-2.5M | ---- | 707.67%6.5M | ---- | 20.81%-1.07M | ---- | 30.56%-1.35M | ---- | 33.33%-1.94M |
Impairment and provisions: | ---- | 3,373.80%13M | ---- | -102.48%-397K | ---- | 131.16%15.98M | ---- | -63.83%6.91M | ---- | 775.95%19.11M |
-Impairment of goodwill | ---- | ---- | ---- | ---- | ---- | --15.63M | ---- | ---- | ---- | --19.31M |
-Other impairments and provisions | ---- | 3,373.80%13M | ---- | -214.74%-397K | ---- | -94.99%346K | ---- | 3,556.00%6.91M | ---- | 92.93%-200K |
Revaluation surplus: | ---- | -98.05%240K | ---- | 345.29%12.34M | ---- | -1,846.53%-5.03M | ---- | -8.28%288K | ---- | -81.40%314K |
-Fair value of investment properties (increase) | ---- | -64.71%277K | ---- | 1,502.04%785K | ---- | -83.50%49K | ---- | 165.18%297K | ---- | -75.49%112K |
-Other fair value changes | ---- | -100.32%-37K | ---- | 327.47%11.55M | ---- | -56,333.33%-5.08M | ---- | -104.46%-9K | ---- | -83.59%202K |
Asset sale loss (gain): | ---- | 92.85%-171K | ---- | -239,100.00%-2.39M | ---- | -98.70%1K | ---- | -78.31%77K | ---- | -67.52%355K |
-Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---1.75M | ---- | ---- | ---- | ---60K | ---- | ---- |
-Loss (gain) on sale of property, machinery and equipment | ---- | 73.49%-171K | ---- | -64,600.00%-645K | ---- | -99.27%1K | ---- | -61.41%137K | ---- | -67.52%355K |
Depreciation and amortization: | ---- | -25.95%34.04M | ---- | -15.70%45.97M | ---- | -12.04%54.54M | ---- | 20.21%62.01M | ---- | 204.19%51.58M |
-Amortization of intangible assets | ---- | -7.30%1.66M | ---- | -59.62%1.79M | ---- | 6.70%4.44M | ---- | -23.20%4.16M | ---- | 0.50%5.42M |
Financial expense | ---- | -20.88%2.04M | ---- | -38.22%2.58M | ---- | -14.69%4.17M | ---- | -35.69%4.89M | ---- | -1.68%7.6M |
Special items | ---- | -64.79%5.92M | ---- | 98.11%16.81M | ---- | 14.91%8.48M | ---- | -32.88%7.38M | ---- | 1,703.35%11M |
Operating profit before the change of operating capital | -128.14%-40.03M | -30.58%152.51M | -1.74%142.25M | -46.13%219.7M | 23.54%144.77M | 11.79%407.82M | -0.22%117.19M | 205.82%364.81M | 1,241.56%117.44M | -19.74%119.29M |
Change of operating capital | ||||||||||
Accounts receivable (increase)decrease | -68.37%70.12M | -164.67%-255.63M | 22.55%221.69M | 182.81%395.3M | 306.11%180.9M | -109.81%-477.38M | 22.26%-87.77M | -230.66%-227.54M | -154.38%-112.9M | 328.41%174.14M |
Accounts payable increase (decrease) | 38.22%-185.44M | -235.69%-118.61M | -217.97%-300.17M | -70.43%87.41M | ---94.4M | 69.14%295.61M | ---- | 378.78%174.77M | ---- | -578.33%-62.69M |
Special items for working capital changes | -92.98%877K | -46.60%26.81M | --12.5M | 185.67%50.21M | ---- | -306.40%-58.61M | ---- | 10.96%28.4M | ---- | 342.83%25.59M |
Cash from business operations | -302.52%-154.46M | -125.90%-194.91M | -67.02%76.27M | 349.50%752.62M | 686.22%231.27M | -50.82%167.44M | 547.76%29.42M | 32.81%340.44M | -97.90%4.54M | 180.86%256.33M |
Other taxs | ---- | 5.57%-50.98M | ---- | -261.69%-53.98M | ---- | 14.68%-14.92M | ---- | -3.96%-17.49M | ---- | 38.62%-16.83M |
Special items of business | 1,364.85%60.92M | ---- | -109.82%-4.82M | ---- | 229.89%49.03M | ---- | -130.59%-37.74M | ---- | 799.98%123.41M | ---- |
Net cash from operations | -230.92%-93.55M | -135.19%-245.88M | -74.51%71.45M | 358.09%698.64M | 3,465.28%280.29M | -52.77%152.51M | -106.51%-8.33M | 34.84%322.95M | -35.62%127.95M | 275.08%239.5M |
Cash flow from investment activities | ||||||||||
Interest received - investment | -34.05%5.91M | 765.43%21.51M | 1,931.29%8.96M | 201.21%2.49M | 0.92%441K | -40.26%825K | -37.84%437K | -40.88%1.38M | -4.74%703K | 156.14%2.34M |
Dividend received - investment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --1.62M | ---- | ---- |
Loan receivable (increase) decrease | -102.92%-1.28M | 190.90%39.73M | 1,466,700.00%44M | -528.09%-43.71M | ---3K | -25.72%10.21M | ---- | 16.27%13.75M | -37.16%2.69M | 724.41%11.82M |
Decrease in deposits (increase) | -92.15%5.06M | 179.26%62.46M | 5,032.11%64.51M | -6,428.17%-78.8M | ---1.31M | -109.47%-1.21M | ---- | 197.01%12.74M | 159.02%12.74M | -1,565.85%-13.13M |
Sale of fixed assets | ---- | -54.99%514K | ---- | 524.04%1.14M | ---- | 40.77%183K | ---- | -60.24%130K | -41.00%154K | -61.48%327K |
Purchase of fixed assets | 6.68%-2.45M | -32.92%-4.73M | -28.87%-2.62M | 74.50%-3.56M | 50.46%-2.03M | 20.68%-13.95M | 62.05%-4.1M | -32.84%-17.59M | -182.13%-10.81M | -77.42%-13.24M |
Purchase of intangible assets | -3,216.89%-7.26M | ---4.62M | ---219K | ---- | ---- | ---- | ---- | ---- | ---- | -3,316.67%-1.44M |
Sale of subsidiaries | ---- | ---- | ---- | ---40.91M | ---40.91M | ---- | ---- | ---2.69M | ---2.69M | ---- |
Acquisition of subsidiaries | ---- | ---- | ---- | -27.26%2.74M | ---- | -74.87%3.77M | ---- | --15.01M | --14.57M | ---- |
Recovery of cash from investments | ---- | ---- | ---- | 88.62%14.08M | ---- | -1.39%7.46M | ---- | 0.19%7.57M | 0.19%7.57M | --7.55M |
Cash on investment | ---- | ---- | ---- | -134.21%-17.27M | ---- | 4.45%-7.37M | ---- | -3.31%-7.72M | 1.14%-7.38M | -0.52%-7.47M |
Other items in the investment business | -74.33%1.3M | 615.63%330K | 147.33%5.05M | -105.30%-64K | -71.24%2.04M | 988.24%1.21M | 15,886.67%7.1M | 94.26%-136K | 98.20%-45K | 21.00%-2.37M |
Net cash from investment operations | -98.93%1.28M | 170.30%115.19M | 386.51%119.68M | -14,613.55%-163.86M | -1,315.39%-41.77M | -95.31%1.13M | -80.35%3.44M | 254.13%24.06M | 174.84%17.49M | -432.76%-15.61M |
Net cash before financing | -148.28%-92.27M | -124.44%-130.69M | -19.87%191.14M | 248.07%534.78M | 4,975.74%238.52M | -55.72%153.64M | -103.36%-4.89M | 54.99%347.01M | -17.06%145.44M | 267.49%223.89M |
Cash flow from financing activities | ||||||||||
New borrowing | ---- | 295.72%8.32M | ---- | -111.01%-4.25M | ---- | -45.56%38.61M | ---- | -52.65%70.92M | -64.02%38.85M | -68.00%149.79M |
Refund | ---794K | ---- | ---- | 96.98%-959K | ---- | 75.75%-31.78M | ---- | 52.81%-131.05M | 73.62%-61.29M | 39.43%-277.74M |
Issuing shares | ---- | ---- | ---- | ---- | ---- | --3.43M | ---- | ---- | ---- | --2.49M |
Interest paid - financing | -23.54%-1.29M | 20.88%-2.04M | 36.79%-1.04M | 38.22%-2.58M | 24.66%-1.65M | 14.69%-4.17M | -2.39%-2.19M | 35.69%-4.89M | 45.99%-2.14M | 1.68%-7.6M |
Dividends paid - financing | ---- | 33.66%-19.38M | -118.16%-4.15M | -7.45%-29.21M | -7.65%-1.9M | -552.28%-27.19M | ---1.77M | 75.77%-4.17M | ---- | -5.89%-17.2M |
Absorb investment income | ---- | --1.69M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Other items of the financing business | -98.16%42K | ---- | 145.57%2.29M | ---- | -335.10%-5.02M | ---- | --2.13M | ---- | ---- | ---- |
Net cash from financing operations | 14.40%-13.81M | 45.55%-38.43M | 39.76%-16.13M | -3.81%-70.59M | 1.39%-26.78M | 37.57%-67.99M | 28.41%-27.16M | 44.80%-108.91M | 74.74%-37.93M | -231.80%-197.29M |
Effect of rate | -197.26%-15.2M | 81.56%-6.21M | 82.93%-5.11M | -245.14%-33.66M | -479.11%-29.95M | 35.74%-9.75M | -125.22%-5.17M | -1,008.68%-15.18M | 14.84%-2.3M | 118.70%1.67M |
Net Cash | -160.62%-106.08M | -136.43%-169.13M | -17.35%175M | 441.98%464.2M | 760.68%211.74M | -64.03%85.65M | -129.81%-32.05M | 794.94%238.1M | 326.53%107.51M | 1,717.28%26.61M |
Begining period cash | -17.56%823.03M | 75.82%998.37M | 75.82%998.37M | 15.43%567.83M | 15.43%567.83M | 82.87%491.93M | 82.87%491.93M | 11.75%269.01M | 11.75%269.01M | -3.01%240.73M |
Cash at the end | -39.93%701.75M | -17.56%823.03M | 55.85%1.17B | 75.82%998.37M | 64.86%749.62M | 15.43%567.83M | 21.51%454.71M | 82.87%491.93M | 42.16%374.22M | 11.75%269.01M |
Cash balance analysis | ||||||||||
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | KPMG | -- | KPMG | -- | KPMG | -- | KPMG | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.